WHITEWORTH TOWN PLSN
GenericsWHITEWORTH TOWN PLSN is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Infectious Disease.
WHITEWORTH TOWN PLSN's Key Drugs
WHITEWORTH TOWN PLSN's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
WHITEWORTH TOWN PLSN's Recent FDA Approvals
New NDA/BLA approvals for WHITEWORTH TOWN PLSN over the last two years — novel drugs only, excluding generics and label supplements.
WHITEWORTH TOWN PLSN's Therapeutic Areas
WHITEWORTH TOWN PLSN's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
WHITEWORTH TOWN PLSN's Top Competitors
WHITEWORTH TOWN PLSN's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
WHITEWORTH TOWN PLSN Pipeline Snapshot
Active clinical trials for WHITEWORTH TOWN PLSN across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1971-04-14
- Latest
- 1987-01-20
- Applications
- 28